Menopause: Identification and Management Source: National Institute for Health and Care Excellence

https://reference.medscape.com/cc2/p10/menopause-identification-and-management-2024a1000jwi?ecd=WNL_drugguide_260204_MSCPREF_obgyn_etid8076355&uac=148436CN&impID=8076355 Overview This Medscape summary of National Institute for Health and Care Excellence (NICE) guidance covers recommendations for women, trans men, and nonbinary people registered female at birth, who currently have menopause-associated symptoms or who will experience menopause in the future. The guideline does not cover people who are currently having gender-affirming hormone therapy. The benefits and risks of hormone-replacement therapy (HRT) described in this guideline only cover the use of HRT within the licensed dosages. For a complete set of recommendations, including on individualised care and tables detailing the effect of HRT on specific health outcomes, refer to the full guideline.